Qin Hu
- Cancer Research top 10%
- MicroRNA in disease regulation 5
-
- RNA Interference and Gene Delivery 7
- RNA modifications and cancer 6
- Advanced biosensing and bioanalysis techniques 4
- Ginseng Biological Effects and Applications 4
- Biomaterials top 10%
-
- Immunotherapy and Immune Responses 7
-
- Nanoplatforms for cancer theranostics 7
-
- Cancer Immunotherapy and Biomarkers 5
- Journals
- PLoS ONE (3 papers)Frontiers in Immunology (2 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qin Hu
69 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 233
- Complementary and alternative medicine 73
- Molecular Biology 606
- Biomaterials 111
- Immunology 174
Countries citing papers authored by Qin Hu
This map shows the geographic impact of Qin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Hu more than expected).
Fields of papers citing papers by Qin Hu
This network shows the impact of papers produced by Qin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Hu. The network helps show where Qin Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qin Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 11 | |
| 15 | 2019 | 53 | |
| 16 | 2018 | 11 | |
| 17 | 2016 | 20 | |
| 18 | 2013 | 50 | |
| 19 | 2012 | 66 | |
| 20 | 2010 | 2 |
About Qin Hu
Qin Hu is a scholar working on Cancer Research, Pharmacology and Immunology, having authored 72 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (7 papers), RNA modifications and cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), MicroRNA in disease regulation (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Ginseng Biological Effects and Applications (4 papers). The work is most often cited by research in Cancer Research (233 citations), Complementary and alternative medicine (73 citations) and Molecular Biology (606 citations). Qin Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiongwei Deng, Wang Sheng, Yan Wu, Yi Zeng, Xiangqian Xiao, Bin Zhao, Zhouwei Zhang, Qun Xue, Zhaoxia Yin and Runtian Wang. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Advanced Healthcare Materials, Nanoscale and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.